Interpreting thresholds for a clinically significant change in health status in asthma and COPD

Health status (or Health-Related Quality of Life) measurement is an established method for assessing the overall efficacy of treatments for asthma and chronic obstructive pulmonary disease (COPD). Such measurements can indicate the potential clinical significance of a treatment's effect. This paper is concerned with methods of estimating the threshold of clinical significance for three widely used health status questionnaires for asthma and COPD: the Asthma Quality of Life Questionnaire, Chronic Respiratory Questionnaire and St George's Respiratory Questionnaire. It discusses the methodology used to obtain such estimates and shows that the estimates appear to be fairly reliable; i.e. for a given questionnaire, similar estimates may be obtained in different studies. These empirically derived thresholds are all mean estimates with confidence intervals around them. The presence of these confidence intervals affects the way in which the thresholds may be used to draw inferences concerning the clinical relevance of clinical trial results. A new system of judging the magnitude of clinically significant results is proposed. Finally, an attempt is made to translate these thresholds into scenarios that illustrate what a clinically significant change with treatment may mean to an individual patient.

[1]  P. Jones,et al.  Health status measurement in chronic obstructive pulmonary disease , 2001, Thorax.

[2]  N. Payne,et al.  Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial , 2000, The Lancet.

[3]  P. Jones,et al.  A comparison of global questions versus health status questionnaires as measures of the severity and impact of asthma. , 1999, The European respiratory journal.

[4]  P. Jones,et al.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease , 1999, Thorax.

[5]  P. Chevalet,et al.  [In clinical practice]. , 1999, La Revue du praticien.

[6]  G. Guyatt,et al.  Interpreting treatment effects in randomised trials , 1998, BMJ.

[7]  M. Wittmann.  [Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease]. , 1997, Pneumologie.

[8]  P. Jones,et al.  Quality of life changes in COPD patients treated with salmeterol. , 1997, American journal of respiratory and critical care medicine.

[9]  D A Redelmeier,et al.  Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. , 1997, American journal of respiratory and critical care medicine.

[10]  J. G. Douglas,et al.  Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. , 1997, Thorax.

[11]  G. Guyatt,et al.  Assessing the minimal important difference in symptoms: a comparison of two techniques. , 1996, Journal of clinical epidemiology.

[12]  J. Wright,et al.  The minimal important difference: who's to say what is important? , 1996, Journal of clinical epidemiology.

[13]  D. Redelmeier,et al.  Spirometry and dyspnea in patients with COPD. When small differences mean little. , 1996, Chest.

[14]  E. van Doorslaer,et al.  Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. , 1995, The European respiratory journal.

[15]  G H Guyatt,et al.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire. , 1994, Journal of clinical epidemiology.

[16]  P. Jones,et al.  Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial. Nedocromil Sodium Quality of Life Study Group. , 1994, The European respiratory journal.

[17]  P. Jones,et al.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.

[18]  G. Guyatt,et al.  Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. , 1992, Thorax.

[19]  P. Jones,et al.  The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.

[20]  G. Guyatt,et al.  Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.

[21]  G. Guyatt,et al.  A measure of quality of life for clinical trials in chronic lung disease. , 1987, Thorax.

[22]  D M Chaput de Saintonge,et al.  Clinical judgment in rheumatoid arthritis. II. Judging 'current disease activity' in clinical practice. , 1983, Annals of the rheumatic diseases.